Funder
National Institutes of Health
Subject
Cell Biology,Molecular Biology,Biochemistry
Reference44 articles.
1. Cancer statistics, 2021;Siegel;CA Cancer J. Clin.,2021
2. Five-year survival with combined nivolumab and ipilimumab in advanced melanoma;Larkin;N. Engl. J. Med.,2019
3. Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study;Robert;Lancet Oncol.,2019
4. Targeting the PD-1 pathway: a promising future for the treatment of melanoma;Mamalis;Arch. Dermatol. Res.,2014
5. Combination of CTLA-4 and PD-1 blockers for treatment of cancer;Rotte;J. Exp. Clin. Cancer Res.,2019
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献